Several hundred cases of myocarditis or myocarditis-like illnesses following the COVID-19 vaccine have been reported in people under 30.
Myocarditis is typically the result of a viral infection like the flu or COVID-19. It creates inflammation in the wall of the heart muscle.
Today the CDC and other federal health agencies will discuss the relatively uncommon condition.
The biggest concern seems to be in the teen and young adult age range, according to the American Academy of Pediatrics.
Teens and young adults make up most of the myocarditis and pericarditis cases after the second dose. This is also despite making up a much smaller percentage of people who received the vaccine.
Around a year ago, concerns of developing myocarditis after contracting COVID-19 are what in part led the big ten to initially cancel its football season.
A new report from the American Heart Association suggests the condition might be temporary and straightforward to treat but because the CDC has seen a higher-than-expected number of people in the 16-24 age group have unconfirmed reports of heart problems they are looking at it further. Despite these cases, many experts are still recommending getting the COVID-19 vaccine. They say the benefits outweigh the potential risks.
©2021 Cox Media Group